Metrics to compare | 688046 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688046PeersSector | |
|---|---|---|---|---|
P/E Ratio | 63.3x | 55.7x | −0.2x | |
PEG Ratio | 0.95 | 0.40 | 0.00 | |
Price/Book | 5.5x | 4.0x | 2.6x | |
Price / LTM Sales | 13.6x | 5.3x | 2.7x | |
Upside (Analyst Target) | 19.8% | 24.1% | 66.0% | |
Fair Value Upside | Unlock | 0.3% | 10.8% | Unlock |
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.